New Data Confirm Survival Benefit of Pembrolizumab in Cervical Cancer
The addition of pembrolizumab (Keytruda) to chemotherapy with or without bevacizumab…
Browsing Tag
Pembrolizumab
ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer
Elana Gotkine
THURSDAY, June 1, 2023 (HealthDay News) -- For women with persistent, recurrent, or metastatic cervical cancer, adding…
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination…
HB-200 in combination with pembrolizumab doubled the objective response rate of 1st-line pembrolizumab for patients with recurrent/metastatic head and neck cancer HOOKIPA is preparing…
Pembrolizumab in Advanced Endometrial Cancer
Adding pembrolizumab (Keytruda) to standard chemotherapy improved progression-free survival (PFS) for…
Choosing a Treatment Regimen for Your Endometrial Cancer Patients
The conversation at the Society of Gynecologic Oncology (SGO) annual meeting was dominated by the two…
AACR: mRNA-4157 Plus Pembrolizumab Beneficial in Melanoma
Elana Gotkine
MONDAY, April 17, 2023 (HealthDay News) -- For patients with completely resected, high-risk cutaneous melanoma, the novel mRNA-based…
Adding Pembrolizumab to Docetaxel Fails to Improve Survival in mCRPC
The addition of pembrolizumab (Keytruda) to docetaxel for patients with metastatic castration-resistant…
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer
SAN FRANCISCO -- Pembrolizumab (Keytruda) monotherapy showed encouraging antitumor activity in patients with papillary…
Modest Survival Gain in Gastric/GEJ Cancer With Chemo Plus Pembrolizumab
Adding pembrolizumab (Keytruda) to chemotherapy modestly improved survival in…
FDA OKs Adjuvant Pembrolizumab for NSCLC
The FDA has approved pembrolizumab (Keytruda) as an adjuvant therapy following surgical…